Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

dual tasking

One in four US doctors make daily, professional use of social media

Survey finds social media helps in managing information overload

Genzyme enters $22.5m RNAi deal with Alnylam in Asia

Programme targets condition affecting heart and nervous system

Eisai’s epilepsy drug Fycompa gets green light in US

Japanese firm predicts global sales of more than $1bn at peak

- PMLiVE

Pfizer pays $680m to buy ADHD drug developer NextWave

Portfolio includes once-daily Quillivant XR

- PMLiVE

Vivus fails to get European backing for obesity treatment Qsiva

EMA raises concerns about drug’s cardiovascular safety

- PMLiVE

How to choose your social media platform

One of the most important factors to consider is the localisation of your audience

- PMLiVE

Former Amgen EVP Roger Perlmutter joins Heptares board

Also has experience at Merck & Co

- PMLiVE

Movember steps up reach with UK out-of-home advertising

From today the Movember mens’ health campaign delivers its message via out-of-home advertising – a first for the charity

- PMLiVE

NHS Trust uses 50’s-style ad campaign to spread flu jab message

Collaborates with Liverpool-based agency Splinter on immunisation adverts

- PMLiVE

GE Healthcare launches Spotify-powered breast cancer initiative

Give A Little Beat jukebox aims to connect people through music

- PMLiVE

Diabetes care recognised at UK awards

Joint working between pharma, NHS and patient organisations key among winners at QiC Diabetes 2012

Europe set to approve first Glivec generic

CHMP backs Teva version of Novartis' blockbuster cancer drug

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links